Status:
COMPLETED
Financing Strategies of Influenza Vaccination in China
Lead Sponsor:
Peking University
Collaborating Sponsors:
Centers for Disease Control and Prevention, China
Fudan University
Conditions:
Influenza Vaccines
Influenza, Human
Eligibility:
All Genders
6+ years
Brief Summary
This trial focuses on influenza vaccination among three recommended groups in China. Data concerning the economic burden of influenza-like illness (ILI), vaccine hesitancy, discrete choice experiment,...
Detailed Description
This trial focuses on influenza vaccination among three recommended groups in China, including children (aged between 6 to 59 months), the elderly (aged 60 years old or above), and adult patients with...
Eligibility Criteria
Inclusion
- (For children group) children aged between 6 to 59 months.
- (For the elderly group) the elderly aged 60 years old or above.
- (For chronic disease patient group) adult patients with chronic diseases aged below 60 years old.
- (For medical staff) general practitioners and vaccination staff.
- Interviewees with informed consent.
Exclusion
- Those cannot be surveyed for physical reasons.
- Those with communication barriers.
- Those who do not agree to participate in the survey.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 10 2021
Estimated Enrollment :
13542 Patients enrolled
Trial Details
Trial ID
NCT04038333
Start Date
August 1 2019
End Date
March 10 2021
Last Update
January 24 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Health Science Center
Beijing, Beijing Municipality, China, 100191
2
Shandong University
Jinan, Shandong, China
3
Fudan University
Shanghai, Shanghai Municipality, China